JO
CDLX icon

John Overdeck’s Cardlytics CDLX Stock Holding History

John Overdeck’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-290
Closed -$318K – 4085
2021
Q1 		$318K Sell
290
-310
-52% -$409K ﹤0.01% 3282
2020
Q4 		$857K Buy
600
+160
+36% +$171K ﹤0.01% 2123
2020
Q3 		$311K Buy
+440
New +$320K ﹤0.01% 2562

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

John Overdeck's CDLX Position: Q1 2026 in Review

John Overdeck sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 28,375 shares — an estimated $326K sold.

John Overdeck first reported a position in CDLX in Q1 2018 and held it in 26 quarters. The position peaked at $6.88M in Q4 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • John Overdeck reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 28,375 Cardlytics shares in Q1 2026, an estimated $326K.
  • John Overdeck first reported a position in Cardlytics in Q1 2018 and held it in 26 quarters.
  • John Overdeck's Cardlytics position peaked at $6.88M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.